Rosemarie Lajara

Summary

Publications

  1. doi request reprint Use of the dipeptidyl peptidase-4 inhibitor linagliptin in combination therapy for type 2 diabetes
    Rosemarie Lajara
    Diabetes America, Health Center At Plano, 1708 Coit Road, Suite 100, Plano, TX 75075, USA
    Expert Opin Pharmacother 13:2663-71. 2012
  2. ncbi request reprint Healthcare professional and patient perceptions of a new prefilled insulin pen versus vial and syringe
    Rosemarie Lajara
    Diabetes Centers of America, Health Center At Plano, 1708 Coit Road Suite 100, Plano, TX 75075, USA
    Expert Opin Drug Deliv 9:1181-96. 2012

Detail Information

Publications2

  1. doi request reprint Use of the dipeptidyl peptidase-4 inhibitor linagliptin in combination therapy for type 2 diabetes
    Rosemarie Lajara
    Diabetes America, Health Center At Plano, 1708 Coit Road, Suite 100, Plano, TX 75075, USA
    Expert Opin Pharmacother 13:2663-71. 2012
    ....
  2. ncbi request reprint Healthcare professional and patient perceptions of a new prefilled insulin pen versus vial and syringe
    Rosemarie Lajara
    Diabetes Centers of America, Health Center At Plano, 1708 Coit Road Suite 100, Plano, TX 75075, USA
    Expert Opin Drug Deliv 9:1181-96. 2012
    ..Usability of a new prefilled insulin pen, FlexTouch® (FT; Novo Nordisk A/S, Bagsvaerd, Denmark), with no push-button extension and low injection force, was compared with vial and syringe (V&S)...